Innoveren Scientific Inc. (IVRN)
OTCMKTS · Delayed Price · Currency is USD
0.0007
+0.0003 (75.00%)
At close: May 6, 2026
Innoveren Scientific Company Description
Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage.
It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023.
The company is headquartered in Tampa, Florida.
Innoveren Scientific Inc.
| Country | United States |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Michael Yurkowsky |
Contact Details
Address: 201 East Kennedy Blvd Tampa, Florida Florida United States | |
| Phone | 844 633 6839 |
Stock Details
| Ticker Symbol | IVRN |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US4041243076 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Michael W. Yurkowsky | Chief Executive Officer and Director |
| Dr. Tanya Rhodes Ph.D. | Chief Scientific Officer |